MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

12 Feb 2024 Evaluate
The sales moved up 27.19% to Rs. 279.74 millions for the December 2023 quarter as compared to Rs. 219.94 millions during the year-ago period.The Company has registered profit of Rs. 48.00  millions for the quarter ended December 2023, a growth of 10.34%  over Rs. 43.50 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 93.19 millions from 67.86 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 279.74 219.94 27.19 881.09 608.93 44.69 902.20 712.88 26.56
Other Income 11.12 13.88 -19.88 26.47 27.67 -4.34 31.65 35.68 -11.29
PBIDT 93.19 67.86 37.33 268.49 177.56 51.21 264.24 214.88 22.97
Interest 0.18 0.29 -37.93 0.37 0.76 -51.32 1.16 1.46 -20.55
PBDT 93.01 67.57 37.65 268.12 176.80 51.65 263.08 213.42 23.27
Depreciation 18.81 9.90 90.00 43.12 27.28 58.06 37.24 33.37 11.60
PBT 74.20 57.67 28.66 225.00 149.52 50.48 225.84 180.05 25.43
TAX 26.20 14.17 84.90 63.94 37.99 68.31 55.64 46.07 20.77
Deferred Tax 6.00 -0.25 -2500.00 6.89 -0.51 -1450.98 -2.84 -0.39 628.21
PAT 48.00 43.50 10.34 161.06 111.53 44.41 170.20 133.98 27.03
Equity 125.11 120.08 4.19 125.11 120.08 4.19 125.11 120.07 4.20
PBIDTM(%) 33.31 30.85 7.97 30.47 29.16 4.50 29.29 30.14 -2.83
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..